Management of rare movement diseases in different world regions
Cèlia Painous(Biomedical Research Networking Center on Neurodegenerative Diseases), Marina A.J. Tijssen(University Medical Center Groningen), Houyam Tibar, Andrea Paola Camargo(Fundación Universitaria de Ciencias de la Salud), Funmilola Taiwo(University College Hospital, Ibadan), Mary F. Kearney, Roopa Rajan(All India Institute of Medical Sciences), Biniyam A. Ayele(Addis Ababa University), Oluwadamilola O. Ojo(University of Lagos), Marı́a José Martı́(Biomedical Research Networking Center on Neurodegenerative Diseases), Daniel Martínez-Ramírez(Tecnológico de Monterrey), Holm Graeßner(University Children's Hospital Tübingen), Mario Cornejo‐Olivas(Universidad Científica del Sur), Emilia Gatto(Universidad de Buenos Aires), Shaimaa I El-Jaafary(Cairo University)
Cited by 3
Related Papers
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy
|Nature|2012|1.2k
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study
|The Lancet Neurology|2023|154
A Statement of the <scp>MDS</scp> on Biological Definition, Staging, and Classification of Parkinson's Disease
|Movement Disorders|2023|83
Validation of Montreal Cognitive Assessment-Basic in a sample of elderly Egyptians with neurocognitive disorders
|Aging & Mental Health|2018|57
Autologous bone marrow-derived stem cells in amyotrophic lateral sclerosis
|Neurology India|2012|55